Measure, treat, repeat: the push to standardize longevity medicine

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Fourth Roundtable of Longevity Clinics sees clinic leaders tackle the ‘luxury diagnostic’ trap and the push for standardized care.

At this weekend’s Roundtable of Longevity Clinics, organized by the International Institute of Longevity and chaired by Buck Institute CEO Eric Verdin MD, leading clinic founders agreed that the longevity sector has reached an inflection point. As patients arrive armed with ChatGPT analysis and insurers begin to engage, the consensus was clear: mature longevity medicine must move beyond static diagnostic snapshotting to a model that diagnoses, treats and re-measures over time.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Phil Newman

Editor-in-Chief

Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE